Fact sheet: Janus Gbl Life Sci

Fund information

Fund name
Janus Global Life Sciences A Acc USD
Fund company manager
Janus Capital Funds
Fund type
SIB
Fund manager
Tom Malley
since 31/03/2000
Fund objective
This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve similar or lower volatility relative to our peers.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

8.83 %

1 Year rank in sector

12/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 1.9 b

FE Risk score

156

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    77.69%
  • UK
    7.39%
  • France
    4.85%
  • Switzerland
    3.78%
  • Japan
    1.88%
  • Biotechnology/Medical
    36.66%
  • Pharmaceuticals
    27.29%
  • Healthcare & Medical Products
    14.87%
  • Others
    9.95%
  • Health Care
    7.02%
  • US Equities
    77.2%
  • International Equities
    20.71%
  • Cash & Cash Equivalents
    1.61%
  • Convertibles
    0.44%
  • Other International Equities
    0.04%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund3.73 %10.86 %8.83 %21.37 %124 %
Sector2.44 %5.7 %6.98 %21.14 %97.17 %
Rank within sector10 / 307 / 3012 / 2912 / 275 / 23
Quartile th2 nd1 st2 nd2 nd1 st

Calendar performance

YTD-20172016201520142013
Fund22.2 %-13.79 %5.69 %32.75 %52.45 %
Sector15.5 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector8 / 2919 / 2918 / 2713 / 248 / 23
Quartile th2 nd3 rd3 rd3 rd2 nd

Risk statistics

Alpha-0.97
Beta1.02
Sharpe0.17
Volatility16.42
Tracking error4.99
Information ratio-0.2
R-Squared0.91

Price movement

52 week high30.68
52 week low23.64
Current bid price0
Current offer price0
Current mid price30.33

Holdings by region

  • 77.69% USA
  • 7.39% UK
  • 4.85% France
  • 3.78% Switzerland
  • 1.88% Japan
  • 1.61% Money Market
  • 1.19% Denmark
  • 0.89% Germany
  • 0.39% Canada
  • 0.3% Hungary

Holdings by sector

  • 36.66% Biotechnology/Medical
  • 27.29% Pharmaceuticals
  • 14.87% Healthcare & Medical Products
  • 9.95% Others
  • 7.02% Health Care
  • 2.6% Hospital
  • 1.61% Cash & Cash Equivalents

Holdings by asset type

  • 77.2% US Equities
  • 20.71% International Equities
  • 1.61% Cash & Cash Equivalents
  • 0.44% Convertibles
  • 0.04% Other International Equities

Individual holdings

  • 3.57% LILLY (ELI) & CO
  • 3.29% SANOFI
  • 3% AETNA INC NEW
  • 2.98% SHIRE PLC
  • 2.97% CELGENE CORP
  • 2.8% ASTRAZENECA PLC
  • 2.55% REGENERON PHARMACEUTICALS INC
  • 2.46% ALLERGAN PLC
  • 2.16% ANTHEM INC
  • 2.16% BIOGEN INC